Letter to the Editor
Methotrexate in interstitial lung disease associated with rheumatoid arthritis
Metotrexato en la neumopatía intersticial asociada a la artritis reumatoide
Luis Arboleya-Rodrígueza,
, Miguel Arias-Guillénb,c,d, Comité de Neumopatías Intersticiales del HUCA
Corresponding author
a Comité multidisciplinar de Neumopatías intersticiales, Hospital Universitario Central de Asturias, Oviedo, Asturias, Spain
b Servicio de Neumología, Hospital Universitario Central de Asturias, Facultad de Medicina de la Universidad de Oviedo, Oviedo, Asturias, Spain
c Instituto de Investigación Sanitaria del Principado de Asturias, Oviedo, Asturias, Spain
d CIBER-Enfermedades Respiratorios, Instituto de Salud Carlos III, Madrid, Spain
Read
2518
Timeswas read the article
631
Total PDF
1887
Total HTML
Share statistics
array:24 [ "pii" => "S2173574322001083" "issn" => "21735743" "doi" => "10.1016/j.reumae.2020.10.009" "estado" => "S300" "fechaPublicacion" => "2022-08-01" "aid" => "1498" "copyright" => "Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología" "copyrightAnyo" => "2020" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Reumatol Clin. 2022;18:441-2" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "Traduccion" => array:1 [ "es" => array:19 [ "pii" => "S1699258X20302783" "issn" => "1699258X" "doi" => "10.1016/j.reuma.2020.10.011" "estado" => "S300" "fechaPublicacion" => "2022-08-01" "aid" => "1498" "copyright" => "Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Reumatol Clin. 2022;18:441-2" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "es" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Carta al Editor</span>" "titulo" => "Metotrexato en la neumopatía intersticial asociada a la artritis reumatoide" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "441" "paginaFinal" => "442" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Methotrexate in interstitial lung disease associated with rheumatoid arthritis" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Luis Arboleya-Rodríguez, Miguel Arias-Guillén" "autores" => array:3 [ 0 => array:2 [ "nombre" => "Luis" "apellidos" => "Arboleya-Rodríguez" ] 1 => array:2 [ "nombre" => "Miguel" "apellidos" => "Arias-Guillén" ] 2 => array:1 [ "colaborador" => "Comité de Neumopatías Intersticiales del HUCA" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S2173574322001083" "doi" => "10.1016/j.reumae.2020.10.009" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173574322001083?idApp=UINPBA00004M" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1699258X20302783?idApp=UINPBA00004M" "url" => "/1699258X/0000001800000007/v2_202306211119/S1699258X20302783/v2_202306211119/es/main.assets" ] ] "itemSiguiente" => array:18 [ "pii" => "S2173574322001095" "issn" => "21735743" "doi" => "10.1016/j.reumae.2021.02.011" "estado" => "S300" "fechaPublicacion" => "2022-08-01" "aid" => "159" "copyright" => "Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Reumatol Clin. 2022;18:442" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>" "titulo" => "Neurobehcet's. Comment: “Neuro-Behçet Disease in the Central University Hospital of Asturias”" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "442" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Neurobehcet's. Comentario: “La enfermedad de Neuro-Behçet en el Hospital Universitario Central de Asturias”" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Otto J. Hernandez Fustes, Carlos Arteaga Rodriguez" "autores" => array:2 [ 0 => array:2 [ "nombre" => "Otto J." "apellidos" => "Hernandez Fustes" ] 1 => array:2 [ "nombre" => "Carlos Arteaga" "apellidos" => "Rodriguez" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173574322001095?idApp=UINPBA00004M" "url" => "/21735743/0000001800000007/v2_202306211245/S2173574322001095/v2_202306211245/en/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S2173574321001374" "issn" => "21735743" "doi" => "10.1016/j.reumae.2020.12.001" "estado" => "S300" "fechaPublicacion" => "2022-08-01" "aid" => "1500" "copyright" => "Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Reumatol Clin. 2022;18:440-1" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>" "titulo" => "Answer to the Letter to the Editor: Methotrexate in interstitial lung disease associated with rheumatoid arthritis" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "440" "paginaFinal" => "441" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Respuesta a la carta al editor: Metotrexato en la neumopatía intersticial asociada a la artritis reumatoide" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Carmen Carrasco Cubero, Eugenio Chamizo Carmona" "autores" => array:2 [ 0 => array:2 [ "nombre" => "Carmen" "apellidos" => "Carrasco Cubero" ] 1 => array:2 [ "nombre" => "Eugenio" "apellidos" => "Chamizo Carmona" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S1699258X2030303X" "doi" => "10.1016/j.reuma.2020.12.001" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1699258X2030303X?idApp=UINPBA00004M" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173574321001374?idApp=UINPBA00004M" "url" => "/21735743/0000001800000007/v2_202306211245/S2173574321001374/v2_202306211245/en/main.assets" ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>" "titulo" => "Methotrexate in interstitial lung disease associated with rheumatoid arthritis" "tieneTextoCompleto" => true "saludo" => "Dear Editor:" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "441" "paginaFinal" => "442" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Luis Arboleya-Rodríguez, Miguel Arias-Guillén" "autores" => array:3 [ 0 => array:4 [ "nombre" => "Luis" "apellidos" => "Arboleya-Rodríguez" "email" => array:1 [ 0 => "arboleya@ser.es" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] 1 => array:3 [ "nombre" => "Miguel" "apellidos" => "Arias-Guillén" "referencia" => array:3 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "aff0015" ] 2 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">d</span>" "identificador" => "aff0020" ] ] ] 2 => array:1 [ "colaborador" => "Comité de Neumopatías Intersticiales del HUCA" ] ] "afiliaciones" => array:4 [ 0 => array:3 [ "entidad" => "Comité multidisciplinar de Neumopatías intersticiales, Hospital Universitario Central de Asturias, Oviedo, Asturias, Spain" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Servicio de Neumología, Hospital Universitario Central de Asturias, Facultad de Medicina de la Universidad de Oviedo, Oviedo, Asturias, Spain" "etiqueta" => "b" "identificador" => "aff0010" ] 2 => array:3 [ "entidad" => "Instituto de Investigación Sanitaria del Principado de Asturias, Oviedo, Asturias, Spain" "etiqueta" => "c" "identificador" => "aff0015" ] 3 => array:3 [ "entidad" => "CIBER-Enfermedades Respiratorios, Instituto de Salud Carlos III, Madrid, Spain" "etiqueta" => "d" "identificador" => "aff0020" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Metotrexato en la neumopatía intersticial asociada a la artritis reumatoide" ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">After reading with interest the article by Carrasco Cubero et al.,<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a> we would like to highlight the remarkable work undertaken, which is necessary to improve the understanding of a clinically relevant aspect such as the relationship between different drugs, including methotrexate (MTX) and rheumatoid arthritis-related interstitial lung disease (RA-ILD). Although we agree with most of the results of the review, and the authors’ opinion about them, we feel it necessary to comment on a recommendation in the conclusions: “It is not necessary to discontinue MTX in patients with RA-ILD, as there is evidence that does not increase the incidence or exacerbation of ILD and it improves survival…” .</p><p id="par0010" class="elsevierStylePara elsevierViewall">The involvement of MTX in pulmonary comorbidity in some RA patients is an unresolved clinical issue. In a sub-analysis of the CIRT trial<a class="elsevierStyleCrossRef" href="#bib0010"><span class="elsevierStyleSup">2</span></a> (a controlled clinical trial analysing the effect of weekly low-dose MTX on the incidence of major cardiovascular events in a population at high baseline risk), patients treated with low-dose MTX (15−20<span class="elsevierStyleHsp" style=""></span>mg/week) had a higher risk of developing pulmonary adverse events than those in the placebo group (HR: 1.42; 95% CI: 1.14–1.77), a risk that tripled for serious pulmonary adverse events (HR: 2.99; 95% CI: 1.34–6.65). Although in the Spanish study,<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a> MTX combined with abatacept did not cause lung deterioration, in another recent study in Japan<a class="elsevierStyleCrossRef" href="#bib0020"><span class="elsevierStyleSup">4</span></a> examining 131 patients with RA-ILD treated with abatacept, the authors found that the main risk factor for lung disease deterioration was the use of MTX combined with abatacept.</p><p id="par0015" class="elsevierStylePara elsevierViewall">Acute MTX-associated pneumonitis (MTX-Pneum) was described more than 30 years ago, and manifests as an acute or subacute condition with dyspnoea, cough, and pulmonary infiltrates; it is most common in the first months of treatment, and is caused by a dose-independent hypersensitivity mechanism. RA-associated interstitial lung disease (RA-ILD), on the other hand, usually presents insidiously and has different clinical and course characteristics. It is important to remember that RA-ILD is a serious disease that, in many cases, drastically shortens the life expectancy of these patients, who are very complex to manage. Its presence makes it unlikely that the disease as a whole can be controlled with MTX in monotherapy.<a class="elsevierStyleCrossRef" href="#bib0025"><span class="elsevierStyleSup">5</span></a> In our opinion, most patients will require biological treatment, which can control the joint inflammatory process and the progression of the lung disease. Furthermore, clinical trials are currently underway on RA-ILD based on anti-fibrotic drugs that have already proven effective in idiopathic pulmonary fibrosis, with promising results.</p><p id="par0020" class="elsevierStylePara elsevierViewall">Although the involvement of MTX in the onset or progression of RA-ILD has been defined, its prescription or maintenance in patients with RA-ILD is a clinical decision that should be carefully studied. There is scientific evidence that pre-existing RA-ILD is a risk factor for MTX-Pneum.<a class="elsevierStyleCrossRefs" href="#bib0030"><span class="elsevierStyleSup">6,7</span></a> However, in patients with known lung disease presenting with acute lung disease, it can be very difficult to differentiate an exacerbation or rapid progression of the underlying chronic process of MTX-Pneum,<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">8</span></a> without invasive tests, such as BAL or cryobiopsy, if the situation allows, which may delay diagnosis and appropriate therapeutic decisions. Moreover, patients with severe forms of RA-ILD, especially those classified under the most frequent subtype, that corresponding to usual interstitial pneumonia, those with progressive fibrosing phenotype, or with associated lower airway pathology, will have limited pulmonary reserve, which would increase mortality if they were to suffer intercurrent MTX-Pneum.</p><p id="par0025" class="elsevierStylePara elsevierViewall">To conclude, we consider that, in patients with RA-ILD, especially if after the corresponding multidisciplinary study, they are classified among the phenotypes with the worst prognosis, MTX should not be prescribed and, if they continue treatment with this drug, our advice is to discontinue it and opt for other therapeutic alternatives, at least until there is sufficient scientific evidence that would entail a change in therapeutic attitude.</p></span>" "pdfFichero" => "main.pdf" "tienePdf" => true "NotaPie" => array:1 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as: Arboleya-Rodríguez L, Arias-Guillén M. Metotrexato en la neumopatía intersticial asociada a la artritis reumatoide. Reumatol Clín. 2022;18:441–442.</p>" ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:8 [ 0 => array:3 [ "identificador" => "bib0005" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Revisión sistemática sobre el impacto de los fármacos en la enfermedad pulmonar intersticial difusa asociada a Artritis Reumatoide" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "C. Carrasco Cubero" 1 => "E. Chamizo Carmona" 2 => "P. Vela Casasempere" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.reuma.2020.04.015" "Revista" => array:6 [ "tituloSerie" => "Reumatol Clin" "fecha" => "2021" "volumen" => "17" "paginaInicial" => "504" "paginaFinal" => "513" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/34756311" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0010" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Adverse effects of low-dose methotrexate: a randomized trial" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "D. Solomon" 1 => "R.J. Glynn" 2 => "E. Karlson" 3 => "F. Lu" 4 => "C. Corrigan" 5 => "J. Colls" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.7326/M19-3369" "Revista" => array:6 [ "tituloSerie" => "Ann Intern Med" "fecha" => "2020" "volumen" => "172" "paginaInicial" => "369" "paginaFinal" => "380" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/32066146" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0015" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Interstitial lung disease: national multicenter study of 263 patients" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "C. Fernández-Díaz" 1 => "S. Castañeda" 2 => "R. Melero" 3 => "R. Loricera" 4 => "F. Ortiz-Sanjuán" 5 => "A. Jun-Mas" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:4 [ "tituloSerie" => "Ann Rheum Dis" "fecha" => "2020" "volumen" => "79 Suppl 1" "paginaInicial" => "968" ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0020" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Long-term deterioration of interstitial lung disease in patients with rheumatoid arthritis treated with abatacept" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "T. Mochizuki" 1 => "K. Ikari" 2 => "K. Yano" 3 => "M. Sato" 4 => "K. Ozakaki" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Modern Rheumatol" "fecha" => "2017" "volumen" => "29" "paginaInicial" => "413" "paginaFinal" => "417" ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0025" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Is methotrexate contra-indicated in lung involvement of rheumatoid arthritis?" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "S.A. Nokhatha" 1 => "R. Harrington" 2 => "R. Conway" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jbspin.2020.06.007" "Revista" => array:6 [ "tituloSerie" => "Joint Bone Spine" "fecha" => "2020" "volumen" => "87" "paginaInicial" => "535" "paginaFinal" => "537" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/32622034" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0030" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Risk factors for methotrexate-induced lung injury in patients with rheumatoid arthritis. A multicenter, case-control study. Methotrexate-Lung Study Group" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "G.S. Alarcón" 1 => "J.M. Kremer" 2 => "M. Macaluso" 3 => "M.E. Weinblatt" 4 => "W. Cannon" 5 => "W.R. Palmer" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.7326/0003-4819-127-5-199709010-00003" "Revista" => array:7 [ "tituloSerie" => "Ann Intern Med" "fecha" => "1997" "volumen" => "127" "paginaInicial" => "356" "paginaFinal" => "364" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9273826" "web" => "Medline" ] ] "itemHostRev" => array:3 [ "pii" => "S1470204520307531" "estado" => "S300" "issn" => "14702045" ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0035" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The relationship of preexisting lung disease to the development of methotrexate pneumonitis in patients with rheumatoid arthritis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "M.R. Golden" 1 => "R.S. Katz" 2 => "R.A. Balk" 3 => "H.E. Golden" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Rheumatol" "fecha" => "1995" "volumen" => "22" "paginaInicial" => "1043" "paginaFinal" => "1047" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/7674228" "web" => "Medline" ] ] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0040" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Acute exacerbation in rheumatoid arthritis-associated interstitial lung disease: a retrospective case control study" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "H. Hozumi" 1 => "Y. Nakamura" 2 => "T. Johkoh" 3 => "H. Sumikawa" 4 => "T. Colby" 5 => "M. Kono" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:3 [ "tituloSerie" => "BMJ Open" "fecha" => "2013" "volumen" => "3" ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/21735743/0000001800000007/v2_202306211245/S2173574322001083/v2_202306211245/en/main.assets" "Apartado" => array:4 [ "identificador" => "8400" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Letters to the Editor" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/21735743/0000001800000007/v2_202306211245/S2173574322001083/v2_202306211245/en/main.pdf?idApp=UINPBA00004M&text.app=https://reumatologiaclinica.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173574322001083?idApp=UINPBA00004M" ]
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 November | 17 | 17 | 34 |
| 2024 October | 58 | 47 | 105 |
| 2024 September | 71 | 30 | 101 |
| 2024 August | 84 | 33 | 117 |
| 2024 July | 107 | 33 | 140 |
| 2024 June | 100 | 32 | 132 |
| 2024 May | 104 | 20 | 124 |
| 2024 April | 128 | 34 | 162 |
| 2024 March | 117 | 26 | 143 |
| 2024 February | 111 | 37 | 148 |
| 2024 January | 130 | 33 | 163 |
| 2023 December | 131 | 24 | 155 |
| 2023 November | 112 | 41 | 153 |
| 2023 October | 79 | 24 | 103 |
| 2023 September | 106 | 37 | 143 |
| 2023 August | 97 | 16 | 113 |
| 2023 July | 40 | 25 | 65 |
| 2023 June | 50 | 25 | 75 |
| 2023 May | 76 | 34 | 110 |
| 2023 April | 49 | 10 | 59 |
| 2023 March | 74 | 19 | 93 |
| 2023 February | 40 | 32 | 72 |
| 2023 January | 5 | 2 | 7 |
| 2022 October | 1 | 0 | 1 |
Show all
